the only license that i can find mentioned in the most recent filings/prs is the "LP" application (licensed producer under MMPR) that was filed on 10/31/13 and later accepted by health canada on 11/11/13...the one I've been waiting for.
It seems that another license has been applied for (and now reviewed and commented on by health canada) for handling a controlled substance, as per todays PR. If this was public info before today, i was not aware.
This is very exiting news for me and further solidifies the company's GDERS business plan.
I have a call into Mike for clarification
There's no question that Abattis has the potential to be the industry leader for all operations relating to MMJ...their plan just has to fall into place, which is happening as we speak.
I welcome any input to my post :)
I'll be buying more tomorrow.
What do you mean you're not in this for tomorrows share price? That you're not a short term holder??
News 
Market Data 
Discover 
